Zorzi, Francesca
Calabrese, Emma
Di Fusco, Davide
De Cristofaro, Elena
Biancone, Livia
Casella, Sara
Palmieri, Giampiero
Monteleone, Giovanni https://orcid.org/0000-0003-1339-9076
Article History
Received: 28 May 2020
Accepted: 28 September 2020
First Online: 19 October 2020
Ethics approval and consent to participate
: Each patient who took part in the study gave written informed consent. The study was approved by the Independent Ethic Committee at the Policlinico Tor Vergata of Rome (Rome, Italy).
: Not applicable.
: GM has filed a patent related to the treatment of inflammatory bowel diseases with Smad7 antisense oligonucleotides. The remaining authors declare no conflict of interest.